Health Condition 1: H100- Mucopurulent conjunctivitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients presenting with the signs and symptoms of Kaphaja Abhishyanda will be selected 2 Patients irrespective of Gender religion and socio-economic status will be included in study
Exclusion criteria
Exclusion criteria: 1 Patients not willing to participate in the study 2 Severe cases of conjunctivitis with complications like corneal ulcers trachoma dacryocystitis etc 3 Eye associated with any other inflammatory and infective ocular conditions 4 Patients with known case of Hypertension Diabetes mellitus and any major systemic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Evaluation of efficacy of darvyadi eye drops and Ciprofloxacin eye drops 2.Comparison of efficacy of darvyadi eye drops and ciporifloxacin eyedrops in the management ofkaphaj abhiushyanda with special reference to acute mucopurulent conjunctivitis 3.Reduction in redness and discharge 4.Relief from discomfort and itching sensation 5.Vision restorationTimepoint: Baseline DAY 1 DAY 8 DAY 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| Relief from symptoms of acute mucopurulent conjunctivitisTimepoint: 15 days | — |
Countries
India
Contacts
Parul Institute of Ayurved